Contract Development and Manufacturing Organisations’ (CDMOs) expansion into more complex biopharmaceuticals, gene therapy and advanced product sectors is prompting a competitive position shift.
This month’s cover feature examines the role that knowledge-graph digital twins are playing as a tool to give CDMOs a competitive edge in their manufacturing capacity.
Elsewhere in this issue, we evaluate how physical artificial intelligence (AI) is becoming a potential gamechanger for biopharma manufacturing operations, with technologies like advanced robotics serving to streamline automative processes. And don’t miss our exclusive interview with UAE-based stem cell specialist CellSave Arabia’s chief operating officer on why stem cells and regenerative medicine could become a cornerstone of healthcare in the coming decades.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
